Evidence map›Paper›PMID 25121745›Full record

ReviewCell host & microbe2014

Collateral damage: microbiota-derived metabolites and immune function in the antibiotic era.

Christopher A Lopez, Dawn D Kingsbury, Eric M Velazquez, Andreas J Bäumler

Abstract readReview
In one paragraph

Review in Cell host & microbe, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Structural-activity relationship ofFrontiers in immunology · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Microbiome Studies in Non-human Primates.Current HIV/AIDS reports · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Gut microbiomes and their metabolites shape human and animal health.Journal of microbiology (Seoul, Korea) · 2018
    Article
  16. Review
  17. The germ-organ theory of non-communicable diseases.Nature reviews. Microbiology · 2018
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christopher A LopezDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA.
Dawn D KingsburyDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA.
Eric M VelazquezDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA.
Andreas J BäumlerDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA. Electronic address: ajbaumler@ucdavis.edu.

Funding

UC Davis Biology ProgramR25GM056765 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI GOMES, ALDRIN V. · 1998 to 2019
$9.7M
Virulence Factors of SalmonellaR01AI044170 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI BAUMLER, ANDREAS J · 1999 to 2022
$8.5M
Microbiota Outgrowth by SalmonellaR01AI096528 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMLER, ANDREAS J · 2011 to 2025
$6.1M
Comparative Medical Science Training ProgramT32OD011147 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JEROEN SAEIJ, Sara Michelle Thomasy · 2012 to 2026
$5.5M
Students Training in Advanced Research (STAR) ProgramT35OD010956 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DANIKA L BANNASCH · 2012 to 2026
$1.6M
Salmonella Host interactionsR37AI044170 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Andreas J Baumler, Renee M Tsolis · 2025 to 2026
$1.2M
Year-Long Exposure to Advanced Research (YEAR) Program for Vet StudentsT32OD010931 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RAYBOULD, HELEN E · 2012 to 2018
$752k
Adherent Invasive E. coli and colitisR21AI107393 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMLER, ANDREAS J · 2013 to 2014
$410k
Mechanisms of Dysbiosis by Attaching and Effacing PathogensF31AI112241 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LOPEZ, CHRISTOPHER · 2014 to 2016
$100k
NIAID NIH HHS AI044170NIAID NIH HHS AI096528NIAID NIH HHS AI107393NIAID NIH HHS AI112241NIAID NIH HHS F31 AI112241NIAID NIH HHS R01 AI044170NIAID NIH HHS R01 AI096528NIAID NIH HHS R21 AI107393NIAID NIH HHS R37 AI044170NIGMS NIH HHS R25 GM056765NIH HHS OD010931NIH HHS OD11147NIH HHS T32 OD010931NIH HHS T32 OD011147NIH HHS T35 OD010956
6 · The paper itself

Abstract

Our long-standing evolutionary association with gut-associated microbial communities has given rise to an intimate relationship, which affects many aspects of human health. Recent studies on the mechanisms that link these microbial communities to immune education, nutrition, and protection against pathogens point to microbiota-derived metabolites as key players during these microbe-host interactions. A disruption of gut-associated microbial communities by antibiotic treatment can result in a depletion of microbiota-derived metabolites, thereby enhancing pathogen susceptibility, impairing immune homeostasis, and contributing to the rise of certain chronic inflammatory diseases. Here, we highlight some of the recently elucidated mechanisms that showcase the impacts of microbiota-derived metabolites on human health.

Indexed as

AnimalsAnti-Bacterial AgentsButyric AcidHomeostasisHumansIntestine, LargeMicrobiotaAnti-Bacterial AgentsButyric Acid

Identifiers

PMID25121745
PMCPMC4151313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.